Clinical Trials on Sepsis at Intensive Care Unit in India

Total 247 results

CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) (BioSanfilippo)

Developmental Delay | Mental Retardation

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Farber Disease (BioFarber) (BioFarber)

Splenomegaly | Hepatomegaly | Ceramidase Deficiency | Farber's Lipogranulomatosis

Germany, India, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH) (BioHoFH)

Lipoprotein Lipase Deficiency | Inborn Error of Lipid Metabolism | Corneal Arcus

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hurler Disease (BioHurler) (BioHurler)

Metabolism, Inborn Errors | Mucopolysaccharidosis Type I | Gargoylism

Germany, India, Sri Lanka, Egypt
Nemours Children's Clinic
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up (CORDMILK-FU)

Hypoxic-Ischemic Encephalopathy | Birth Asphyxia

India
National Eye Institute (NEI)

Completed

Molecular Genetics of Retinal Degenerations

Retinal Degeneration | Retinitis Pigmentosa

United States, India, Pakistan, China
Grifols Therapeutics LLC
Instituto Grifols, S.A.

Completed

Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia (IG0902)

Congenital Afibrinogenemia

India, United States, Italy, Lebanon
Takeda

Recruiting

A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India

Hunter Syndrome

India
Novartis Pharmaceuticals

Completed

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Sickle Cell Disease (SCD)

India
Nemours Children's Clinic
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries (CORDMILK)

Hypoxic-Ischemic Encephalopathy | Birth Asphyxia

India
The Hospital for Sick Children
Terry Fox Foundation

Active, not recruiting

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

Retinoblastoma

Canada, Chile, India, Singapore
Novo Nordisk A/S

Completed

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries (HAEMOcare)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

India, Morocco, South Africa, Oman
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Hyaline Fibromatosis Syndrome (BioHFS) (BioHFS)

Skin and Connective Tissue Diseases | Hyaline Membrane Disease | Hyalinosis | Juvenile Hyaline Fibromatosis | Fibromatosis Hyalinica Multiplex Juvenilis

Germany, Sri Lanka, India
Pharmazz, Inc.

Recruiting

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

Hypoxic-Ischemic Encephalopathy | Neonatal Encephalopathy | Neonatal Asphyxia

India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Sly Disease (MPS VII) (BioSly) (BioSly)

Developmental Delay | Splenomegaly | Hepatomegaly | Skeletal Abnormalities

Germany, India, Sri Lanka, Egypt
Mayo Clinic

Completed

The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)

Sepsis | Shock | Critical Illness | Respiratory Failure | Bleeding | Trauma | Coma

China, Brazil, Belarus, Serbia, India, Turkey, Bosnia and Herzegovina, Croatia, Dominican Republic, Ireland, Mexico, Mongolia, Pakistan, Philippines, Poland, Saudi Arabia, Uganda
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Krabbe Disease (BioKrabbe) (BIOKRABBE)

Krabbe Disease

Egypt, Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gaucher Disease: BioGaucher (BioGaucher) (BioGaucher)

Splenomegaly | Hepatomegaly

Germany, India, Sri Lanka
Medexus Pharma, Inc.

Terminated

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

Hemophilia B

United States, United Kingdom, India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Morquio Disease (BioMorquio) (BioMorquio)

Morquio Syndrome A | Morquio Syndrome | Morquio B Disease | Accumulation of Mucopolysaccharides

Germany, India, Sri Lanka, Egypt
Sheri Kashmir Institute of Medical Sciences
University of Pennsylvania; Indian Heart Rhythm Society; Sri Jayadeva Institute...

Active, not recruiting

South Asian Arrhythmogenic Cardiomyopathy Registry

Ventricular Tachycardia | Sudden Cardiac Death | Arrhythmogenic Right Ventricular Cardiomyopathy | Arrhythmogenic Right Ventricular Dysplasia | Arrhythmogenic Ventricular Cardiomyopathy | Arrhythmogenic Cardiomyopathy

United States, India
Ferring Pharmaceuticals

Completed

A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency

Idiopathic Growth Hormone Deficiency

Hungary, India, Israel, Poland, Romania, Russian Federation, Ukraine
KemPharm Denmark A/S

Terminated

Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3

Gaucher Disease, Type 1 | Gaucher Disease, Type 3

India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis) (BioCystinosis)

Hypophosphatemia | Photophobia | Renal Fanconi Syndrome

Germany, India, Sri Lanka
Instituto Grifols, S.A.

Withdrawn

FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis

Hypofibrinogenemia | Congenital Afibrinogenemia

India, Turkey, Lebanon, United States, Bulgaria
Erydel

Completed

International Ataxia Rating Scale in Younger Patients

Ataxia Telangiectasia

Italy, United States, India, Israel
CENTOGENE GmbH Rostock

Completed

Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease (LYSO-PROOF)

Lysosomal Storage Diseases | Sphingolipidoses | Gaucher Disease

Albania, Greece, India, Israel, Morocco, Pakistan, Spain
CENTOGENE GmbH Rostock

Terminated

Biomarker for Cystic Fibrosis (BioCyFi)

Pancreatitis | Failure to Thrive | Meconium Ileus | Breathlessness | Lung Infection | Chronic Nasal Congestion | Clubbing Toes

India, Sri Lanka, Albania, Georgia, Pakistan
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Patients With Fabry Disease (BioFabry) (BioFabry)

Chronic Kidney Disease | Hearing Loss | Angiokeratomas | Ocular Abnormalities

Sri Lanka, India, Germany
Baxalta now part of Shire

Completed

BAX 326 Pediatric Study

Hemophilia B

Russian Federation, Ukraine, India, Poland, Romania, United Kingdom
Forma Therapeutics, Inc.
Novo Nordisk A/S

Recruiting

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Sickle Cell Disease

Nigeria, India, Oman
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease (BioMeta)

Muscle Weakness | Peripheral Neuropathy

Egypt, Germany, India, Sri Lanka
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Anemia

India
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Maroteaux-Lamy Disease (BioMaroteaux) (BioMaroteaux)

Lung Diseases | Eye Abnormalities | Lysosomal Storage Disease | Macroglossia | Obstructive Sleep Apnoea

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Glycogen Storage Diseases (BioGlycogen) (BioGlycogen)

Fructose Metabolism, Inborn Errors | Glycogen Storage Disease Type II | Glycogen Storage Disease | Glycogen Storage Disease Type V | Glycogen Storage Disease Type I | Glycogen Storage Disease Type III | Glycogen Storage Disease Type VII | Glycogen Storage Disease Type IV | Glycogen Storage Disease Type... and other conditions

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) (BioGM1/BioGM2)

Seizures | Mental Retardation | Hepato-splenomegaly | Dysostosis Multiplex

Egypt, Germany, India, Sri Lanka
NICHD Global Network for Women's and Children's...
Thomas Jefferson University; Thrasher Research Fund; RTI International

Completed

ASPIRIN: Neurodevelopmental Follow-up Trial

Neurodevelopmental Abnormality

United States, Zambia, Congo, The Democratic Republic of the, India, Pakistan, Guatemala
Octapharma

Completed

Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

Congenital Fibrinogen Deficiency | Afibrinogenemia

Iran, Islamic Republic of, United States, Bulgaria, India, Switzerland, United Kingdom
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Niemann Pick Type C Disease (BioNPC) (BioNPC)

Niemann-Pick Disease, Type C | Niemann-Pick Disease

Germany, India, Sri Lanka
Astellas Pharma Inc

Completed

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

Belgium, France, Germany, Spain, United States, India, Canada, Brazil, Switzerland, Austria, Croatia, Netherlands, Poland, Czech Republic, United Kingdom
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Pompe Disease (BioPompe) (BioPompe)

Lung Disease | Cerebral Aneurysm | Macroglossia | Cardiac Diseases | Obstructive Sleep Apnoea | Muscular Weakness | Hepato-splenomegaly

Germany, India, Sri Lanka
Exvastat Ltd.

Withdrawn

A Randomized Study to Investigate the Effect of Intravenous Imatinib on the Amount of Oxygen in the Lungs and Blood of Adults With COVID-19 Needing Mechanical Ventilation and Supportive Care. (IMPRESS COVID)

Covid19 | Acute Respiratory Distress Syndrome | ARDS | COVID-19 Acute Respiratory Distress Syndrome | Pulmonary Oedema

India
CENTOGENE GmbH Rostock

Terminated

Biomarker for Alport Syndrome (BioAlport) (BioAlport)

Nephritis, Hereditary | Hematuria-Nephropathy-Deafness Syndrome

India, Sri Lanka, Albania, Georgia, Lithuania, Pakistan, Romania
Novo Nordisk A/S

Completed

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period (guardian 10)

Congenital Bleeding Disorder | Haemophilia A

India
LIB Therapeutics LLC

Completed

Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH

Homozygous Familial Hypercholesterolemia

United States, Israel, Norway, South Africa, Turkey, India
Columbia University
International Agency for Research on Cancer

Recruiting

InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort (NICHE)

Acute Lymphoblastic Leukemia | Nutrition Aspect of Cancer | Genetic Predisposition | Microtia

United States, Guatemala, Brazil, Honduras, India, Tanzania
CENTOGENE GmbH Rostock

Completed

Biomarker for Hereditary AngioEdema Disease (BioHAE)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | C1 Esterase Inhibitor Deficiency | HAE | Angio Edema | C4 Deficiency | Hereditary Angioedema Type III

Turkey, Armenia, Georgia, India, Peru, Poland, Romania
Genzyme, a Sanofi Company

Active, not recruiting

Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B (ATLAS-PEDS)

Hemophilia

Canada, Italy, Turkey, Spain, United States, India
Octapharma

Completed

Study to Investigate Immunogenicity, Efficacy and Safety of Treatment With Human-cl rhFVIII

Severe Hemophilia A

United States, France, Canada, United Kingdom, India, Georgia, Moldova, Republic of, Poland, Ukraine
Christian Medical College, Vellore, India

Unknown

Musculoskeletal Function in Hemophilia

Hemophilia

India, Argentina, Brazil, Egypt, Iran, Islamic Republic of, Singapore, South Africa, Thailand, Venezuela

Clinical Trials on Sepsis at Intensive Care Unit in India

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations